DOCSLIB.ORG

The Leukemia-Associated Transcription Repressor AML1/MDS1/EVI1 Requires Ctbp to Induce Abnormal Growth and Di€Erentiation of Mu

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Leukemia-Associated Transcription Repressor AML1/MDS1/EVI1 Requires Ctbp to Induce Abnormal Growth and Di€Erentiation of Mu Oncogene (2002) 21, 3232 ± 3240 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and dierentiation of murine hematopoietic cells Vitalyi Senyuk1, Soumen Chakraborty1, Fady M Mikhail1,2, Rui Zhao1, Yiqing Chi1 and Giuseppina Nucifora*,1 1Department of Pathology and The Cancer Center, University of Illinois at Chicago, Chicago, Illinois, USA; 2Clinical Pathology Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt The leukemia-associated fusion gene AML1/MDS1/ (ME) genes, is a product of the (3;21)(q26;q22) EVI1 (AME) encodes a chimeric transcription factor translocation that is associated with de novo and that results from the (3;21)(q26;q22) translocation. This therapy-related myelodysplastic syndrome/acute mye- translocation is observed in patients with therapy-related loid leukemia (t-MDS/AML) patients, and to a lesser myelodysplastic syndrome (MDS), with chronic myelo- extent with chronic myelogenous leukemia (CML) genous leukemia during the blast crisis (CML-BC), and patients during the blast crisis of their disease (Rubin with de novo or therapy-related acute myeloid leukemia et al., 1990; Nucifora et al., 1993). The AML1 gene (AML). AME is obtained by in-frame fusion of the (also known as CBFA2, PEBP2 or RUNX1) encodes AML1 and MDS1/EVI1 genes. We have previously the DNA-binding subunit of the core-binding tran- shown that AME is a transcriptional repressor that scription factor (CBF). AML1 interacts with the other induces leukemia in mice. In order to elucidate the role subunit of CBF, CBFb, which has no DNA-binding of AME in leukemic transformation, we investigated the domain. AML1 consists of a N-terminal DNA-binding interaction of AME with the transcription co-regulator domain with partial homology to the product of CtBP1 and with members of the histone deacetylase Drosophila segmentation gene runt, and a C-terminal (HDAC) family. In this report, we show that AME activation domain that interacts with transcription co- physically interacts in vivo with CtBP1 and HDAC1 and regulators (Ogawa et al., 1993a, b). AML1 is essential that these co-repressors require distinct regions of AME for de®nitive murine hematopoiesis (Wang et al., 1996; for interaction. By using reporter gene assays, we Okuda et al., 1996) and is involved in chromosomal demonstrate that AME represses gene transcription by abnormalities associated with human leukemias (Zent CtBP1-dependent and CtBP1-independent mechanisms. et al., 1997; Roulston et al., 1998) including T-cell Finally, we show that the interaction between AME and leukemia (Mikhail et al., 2002). ME is a DNA-binding CtBP1 is biologically important and is necessary for zinc-®nger transcription factor and a longer form of growth upregulation and abnormal dierentiation of the the leukemia-associated protein EVI1 (Fears et al., murine hematopoietic precursor cell line 32Dc13 and of 1996; Soderholm et al., 1997). ME contains a murine bone marrow progenitors. conserved N-terminal region, called PR domain, two Oncogene (2002) 21, 3232 ± 3240. DOI: 10.1038/sj/ sets of DNA-binding Cys2His2-type zinc-®nger do- onc/1205436 mains, a proline-rich central domain, and an acidic C- terminal domain. The evolutionarily conserved PR Keywords: AML1; MDS1; EVI1; t(3;21); CtBP1; domain was ®rst identi®ed in the RIZ1 protein and in HDAC1 the PRDI-BF1/BLIMP1 transcriptional repressor (Huang, 1994; Fears et al., 1996). ME is expressed in several tissues but is not detected in normal hemato- poietic cells (Fears et al., 1996). Both AML1 and ME Introduction are transcriptional activators (Zhang et al., 1996; Soderholm et al., 1997), whereas AME is a transcrip- The AML1/MDS1/EVI1 (AME) fusion gene, obtained tional repressor (Zent et al., 1996). AME consists of by in frame fusion of the AML1 and MDS1/EVI1 the DNA-binding domain of AML1 fused to almost the entire ME including the PR domain (Nucifora et al., 1994). AME potentially possesses the ability to bind both the AML1- and ME-target promoters. *Correspondence: G Nucifora, Department of Pathology and The Recently, it was shown that AME induces leukemia Cancer Center, Molecular Biology Research Building, M/C 737, in mice transplanted with syngeneic bone marrow cells University of Illinois at Chicago, 900 South Ashland Avenue, that express AME (Cuenco et al., 2000). The pathways Chicago, Illinois, IL 60607, USA; E-mail: [email protected] Received 21 November 2001; revised 15 February 2002; accepted through which AME induces cell transformation and 21 February 2002 leukemia are still unknown. It is possible that AME AME de-regulates growth and differentiation via CtBP V Senyuk et al 3233 could inappropriately repress the expression of genes to a much tighter chromatin structure which is that are primary targets of AML1 and ME by presumably inaccessible to transcription factors (Gro- inappropriate recruitment of transcription repressors zinger et al., 1999). Two distinct classes of HDACs at the promoter site, as it was proposed for AML1/ have been identi®ed in mammalian cells. HDAC1, ETO and PML/RARa (Lin and Evans, 2000; Minucci HDAC2, HDAC3, and HDAC8 belong to class I and et al., 2000). It was shown recently that EVI1 interacts are homologous to yeast Rpd3 and Xenopus HDACm with the co-repressor CtBP (Izutsu et al., 2001; Palmer proteins, with a single deacetylase domain at the N- et al., 2001; Chakraborty et al., 2001). CtBP was ®rst terminus. HDAC4, HDAC5, HDAC6, HDAC7, and identi®ed as a protein that binds to the C-terminal HDAC9 are members of class II and are similar to region of the adenovirus E1A protein (Schaeper et al., yeast Hda1 with one or two catalytic domains in their 1995) and it is a well-characterized transcriptional co- C-terminal regions (Bertos et al., 2001). In order to repressor (Turner and Crossley, 2001). CtBP also binds elucidate the potential role of HDACs in AME- to BKLF, FOG, AREB6 (Turner and Crossley, 1998), mediated transcription repression, we tested the Knirps, Kruppel, Snail (Nibu et al., 1998; Keller et al., interaction between HA-AME and Flag-tagged 2000), ZEB (Postigo and Dean, 1999), polycomb HDAC1, 74, 75, and 76. The results are shown in proteins (Sewalt et al., 1999) and other transcription Figure 3. We found that AME strongly interacts with co-regulators with the consensus motif PXDLX to HDAC1 (Figure 3, lane 2), but has a weak or no enhance transcription repression. In this study, we interaction with HDAC4, HDAC5, and HDAC6 investigate the interaction of AME with the transcrip- (Figure 3, lanes 3 to 5). tion co-regulator CtBP1 and with members of the To identify the region of AME that is necessary for histone deacetylase (HDAC) family. We show that the interaction with HDAC1, we used the AME AME interacts with CtBP1 and HDAC1 through deletion mutants shown in Figure 1 in co-IP assays. dierent domains and represses gene transcription by The results show that whereas the full length AME and CtBP1-dependent and CtBP1-independent mechanisms. the deletion mutants AME-1184, AME-994, and AME- More importantly, we also show that the interaction 704 were co-immunoprecipitated by anti-Flag anti- between AME and CtBP1 is functionally important bodies that recognize the Flag-tagged HDAC1 (Figure and is required for maximum cell growth upregulation 4, lanes 2 to 5), the shortest deletion mutant AME-374 by AME and for abnormal dierentiation and was not co-immunoprecipitated by anti-Flag antibodies immortalization of murine bone marrow progenitors. (Figure 4, lane 11). These results suggest that the interaction between AME and HDAC1 requires the aa region 374 to 704. This region includes the entire proximal zinc-®nger domain and a small part of the Results PR domain from ME. It was reported that HDAC1 interacts with CtBP1 in vivo (Sundqvist et al., 1998). To AME interacts with the co-repressor CtBP1 con®rm that AME does not require CtBP1 for CtBP1 binds to the amino acid (aa) pentapeptide motif HDAC1 interaction, we tested the ability of AME C- PXDLX. The AME fusion protein has two potential mutant to co-IP with HDAC1. The results, shown in CtBP1 binding sites: PFDLT (aa 1036 to 1040) and Figure 5, indicate that full length AME (lane 2 and 4) PLDLS (aa 1067 to 1071). To determine whether AME and AME-C (lanes 3 and 5) interact with HDAC1, and associates with CtBP1 at these consensus motifs we therefore further con®rm that the interaction between tested the full length AME and the AME point AME and HDAC1 does not require CtBP1. However, mutants A, B, and C (Figure 1) in co-immunoprecipi- our data do not indicate whether the interaction is tation (co-IP) assays. The A-mutant has a DL to AS direct. substitution in the proximal site (PFDLT to PFAST); the B-mutant has the same substitution in the distal AME co-localizes in the nucleus with CtBP1 or HDAC1 site (PLDLS to PLASS); the C-mutant has both sites mutated. As shown in Figure 2, the wild type AME The interaction between AME and either CtBP1 or (lane 2) and the A-mutant (lane 3) interact with CtBP1. HDAC1 was also con®rmed by confocal microscopy In contrast, the B- and C-mutants, which have the DL analysis of 293 cells that were co-transfected with HA- to AS substitution in the distal site (PLDLS, aa 1067 AME and either Flag-CtBP1 or Flag-HDAC1. As to 1071), were not co-immunoprecipitated with CtBP1 shown in Figure 6, AME (Figure 6, top panels in red (Figure 2, lanes 4 and 5). These results indicate that the color) co-localizes with either CtBP1 or HDAC1 distal PLDLS site has a very strong anity for CtBP1 (Figure 6, middle panels in green color) in the cell and that the mutations DL to AS in this site abrogate nucleus.
Load more

Recommended publications
  • A Pathogenic Ctbp1 Missense Mutation Causes Altered Cofactor Binding and Transcriptional Activity
    neurogenetics (2019) 20:129–143 https://doi.org/10.1007/s10048-019-00578-1 ORIGINAL ARTICLE A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity David B. Beck1 & T. Subramanian2 & S. Vijayalingam2 & Uthayashankar R. Ezekiel3 & Sandra Donkervoort4 & Michele L. Yang5 & Holly A. Dubbs6 & Xilma R. Ortiz-Gonzalez7 & Shenela Lakhani8 & Devorah Segal9 & Margaret Au10 & John M. Graham Jr10 & Sumit Verma11 & Darrel Waggoner12 & Marwan Shinawi13 & Carsten G. Bönnemann4 & Wendy K. Chung14 & G. Chinnadurai2 Received: 23 October 2018 /Revised: 18 March 2019 /Accepted: 9 April 2019 /Published online: 30 April 2019 # Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract We previously reported a pathogenic de novo p.R342W mutation in the transcriptional corepressor CTBP1 in four independent patients with neurodevelopmental disabilities [1]. Here, we report the clinical phenotypes of seven additional individuals with the same recurrent de novo CTBP1 mutation. Within this cohort, we identified consistent CtBP1-related phenotypes of intellectual disability, ataxia, hypotonia, and tooth enamel defects present in most patients. The R342W mutation in CtBP1 is located within a region implicated in a high affinity-binding cleft for CtBP-interacting proteins. Unbiased proteomic analysis demonstrated reduced interaction of several chromatin-modifying factors with the CtBP1 W342 mutant. Genome-wide transcriptome analysis in human glioblastoma cell lines expressing -CtBP1 R342 (wt) or W342 mutation revealed changes in the expression profiles of genes controlling multiple cellular processes. Patient-derived dermal fibroblasts were found to be more sensitive to apoptosis during acute glucose deprivation compared to controls. Glucose deprivation strongly activated the BH3-only pro-apoptotic gene NOXA, suggesting a link between enhanced cell death and NOXA expression in patient fibroblasts.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • A Mechanism of COOH–Terminal Binding Protein– Mediated Repression
    A Mechanism of COOH–Terminal Binding Protein– Mediated Repression Alison R. Meloni,1 Chun-Hsiang Lai,2 Tso-Pang Yao,2 and Joseph R. Nevins1,3 Departments of 1Molecular Genetics and Microbiology and 2Pharmacology and Cancer Biology and 3Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina Abstract repression involves the recruitment of histone deacetylase The E2F4 and E2F5 proteins specifically associate with (HDAC) to E2F site–containing promoters, presumably the Rb-related p130 protein in quiescent cells to repress resulting in an alteration of chromatin conformation that transcription of various genes encoding proteins hinders transcription (7-9). important for cell growth. A series of reports has Several observations suggest that additional events, inde- provided evidence that Rb-mediated repression involves pendent of HDAC recruitment, may contribute to the both histone deacetylase (HDAC)–dependent and repression. For example, many genes subject to E2F/Rb- HDAC-independent events. Our previous results mediated repression are not derepressed by treatment with the suggest that one such mechanism for Rb-mediated HDAC inhibitor trichostatin A (7). Moreover, Rb mutants that repression, independent of recruitment of HDAC, can no longer interact with HDAC are still capable of repressing involves the recruitment of the COOH-terminal binding transcription (10, 11). Based on these observations, it would protein (CtBP) corepressor, a protein now recognized to seem that HDAC-independent mechanisms of transcriptional play a widespread role in transcriptional repression. We repression contribute to the Rb control of transcription. Indeed, now find that CtBP can interact with the histone several Rb-interacting proteins, such as the chromatin remodel- acetyltransferase, cyclic AMP–responsive element– ing complex proteins BRG1 and human BRM, the methyl- binding protein (CREB) binding protein, and inhibit its transferase protein SUV39H1, and RBP1, have been shown to ability to acetylate histone.
    [Show full text]
  • Supp Table 6.Pdf
    Supplementary Table 6. Processes associated to the 2037 SCL candidate target genes ID Symbol Entrez Gene Name Process NM_178114 AMIGO2 adhesion molecule with Ig-like domain 2 adhesion NM_033474 ARVCF armadillo repeat gene deletes in velocardiofacial syndrome adhesion NM_027060 BTBD9 BTB (POZ) domain containing 9 adhesion NM_001039149 CD226 CD226 molecule adhesion NM_010581 CD47 CD47 molecule adhesion NM_023370 CDH23 cadherin-like 23 adhesion NM_207298 CERCAM cerebral endothelial cell adhesion molecule adhesion NM_021719 CLDN15 claudin 15 adhesion NM_009902 CLDN3 claudin 3 adhesion NM_008779 CNTN3 contactin 3 (plasmacytoma associated) adhesion NM_015734 COL5A1 collagen, type V, alpha 1 adhesion NM_007803 CTTN cortactin adhesion NM_009142 CX3CL1 chemokine (C-X3-C motif) ligand 1 adhesion NM_031174 DSCAM Down syndrome cell adhesion molecule adhesion NM_145158 EMILIN2 elastin microfibril interfacer 2 adhesion NM_001081286 FAT1 FAT tumor suppressor homolog 1 (Drosophila) adhesion NM_001080814 FAT3 FAT tumor suppressor homolog 3 (Drosophila) adhesion NM_153795 FERMT3 fermitin family homolog 3 (Drosophila) adhesion NM_010494 ICAM2 intercellular adhesion molecule 2 adhesion NM_023892 ICAM4 (includes EG:3386) intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)adhesion NM_001001979 MEGF10 multiple EGF-like-domains 10 adhesion NM_172522 MEGF11 multiple EGF-like-domains 11 adhesion NM_010739 MUC13 mucin 13, cell surface associated adhesion NM_013610 NINJ1 ninjurin 1 adhesion NM_016718 NINJ2 ninjurin 2 adhesion NM_172932 NLGN3 neuroligin
    [Show full text]
  • Transcriptional and Epigenetic Control of Brown and Beige Adipose Cell Fate and Function
    REVIEWS Transcriptional and epigenetic control of brown and beige adipose cell fate and function Takeshi Inagaki1,2, Juro Sakai1,2 and Shingo Kajimura3 Abstract | White adipocytes store excess energy in the form of triglycerides, whereas brown and beige adipocytes dissipate energy in the form of heat. This thermogenic function relies on the activation of brown and beige adipocyte-specific gene programmes that are coordinately regulated by adipose-selective chromatin architectures and by a set of unique transcriptional and epigenetic regulators. A number of transcriptional and epigenetic regulators are also required for promoting beige adipocyte biogenesis in response to various environmental stimuli. A better understanding of the molecular mechanisms governing the generation and function of brown and beige adipocytes is necessary to allow us to control adipose cell fate and stimulate thermogenesis. This may provide a therapeutic approach for the treatment of obesity and obesity-associated diseases, such as type 2 diabetes. Interscapular BAT Adipose tissue has a central role in whole-body energy subjects who had previously lacked detectable BAT Brown adipose tissue (BAT) is a homeostasis. White adipose tissue (WAT) is the major depots before cold exposure, presumably owing to the specialized organ that adipose organ in mammals. It represents 10% or more emergence of new thermogenic adipocytes. This, then, produces heat. BAT is localized of the body weight of healthy adult humans and is leads to an increase in non-shivering thermogenesis in the interscapular and 6–9 perirenal regions of rodents specialized for the storage of excess energy. Humans and/or an improvement in insulin sensitivity . These and infants.
    [Show full text]
  • Overview of Research on Fusion Genes in Prostate Cancer
    2011 Review Article Overview of research on fusion genes in prostate cancer Chunjiao Song1,2, Huan Chen3 1Medical Research Center, Shaoxing People’s Hospital, Shaoxing University School of Medicine, Shaoxing 312000, China; 2Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing 312000, China; 3Key Laboratory of Microorganism Technology and Bioinformatics Research of Zhejiang Province, Zhejiang Institute of Microbiology, Hangzhou 310000, China Contributions: (I) Conception and design: C Song; (II) Administrative support: Shaoxing Municipal Health and Family Planning Science and Technology Innovation Project (2017CX004) and Shaoxing Public Welfare Applied Research Project (2018C30058); (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: C Song; (V) Data analysis and interpretation: H Chen; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Chunjiao Song. No. 568 Zhongxing Bei Road, Shaoxing 312000, China. Email: [email protected]. Abstract: Fusion genes are known to drive and promote carcinogenesis and cancer progression. In recent years, the rapid development of biotechnologies has led to the discovery of a large number of fusion genes in prostate cancer specimens. To further investigate them, we summarized the fusion genes. We searched related articles in PubMed, CNKI (Chinese National Knowledge Infrastructure) and other databases, and the data of 92 literatures were summarized after preliminary screening. In this review, we summarized approximated 400 fusion genes since the first specific fusion TMPRSS2-ERG was discovered in prostate cancer in 2005. Some of these are prostate cancer specific, some are high-frequency in the prostate cancer of a certain ethnic group. This is a summary of scientific research in related fields and suggests that some fusion genes may become biomarkers or the targets for individualized therapies.
    [Show full text]
  • Novel Mechanisms of Transcriptional Regulation by Leukemia Fusion Proteins
    Novel mechanisms of transcriptional regulation by leukemia fusion proteins A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirement for the degree of Doctor of Philosophy in the Department of Cancer and Cell Biology of the College of Medicine by Chien-Hung Gow M.S. Columbia University, New York M.D. Our Lady of Fatima University B.S. National Yang Ming University Dissertation Committee: Jinsong Zhang, Ph.D. Robert Brackenbury, Ph.D. Sohaib Khan, Ph.D. (Chair) Peter Stambrook, Ph.D. Song-Tao Liu, Ph.D. ABSTRACT Transcription factors and chromatin structure are master regulators of homeostasis during hematopoiesis. Regulatory genes for each stage of hematopoiesis are activated or silenced in a precise, finely tuned manner. Many leukemia fusion proteins are produced by chromosomal translocations that interrupt important transcription factors and disrupt these regulatory processes. Leukemia fusion proteins E2A-Pbx1 and AML1-ETO involve normal function transcription factor E2A, resulting in two distinct types of leukemia: E2A-Pbx1 t(1;19) acute lymphoblastic leukemia (ALL) and AML1-ETO t(8;21) acute myeloid leukemia (AML). E2A, a member of the E-protein family of transcription factors, is a key regulator in hematopoiesis that recruits coactivators or corepressors in a mutually exclusive fashion to regulate its direct target genes. In t(1;19) ALL, the E2A portion of E2A-Pbx1 mediates a robust transcriptional activation; however, the transcriptional activity of wild-type E2A is silenced by high levels of corepressors, such as the AML1-ETO fusion protein in t(8;21) AML and ETO-2 in hematopoietic cells.
    [Show full text]
  • Identification of Genomic Targets of Krüppel-Like Factor 9 in Mouse Hippocampal
    Identification of Genomic Targets of Krüppel-like Factor 9 in Mouse Hippocampal Neurons: Evidence for a role in modulating peripheral circadian clocks by Joseph R. Knoedler A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Neuroscience) in the University of Michigan 2016 Doctoral Committee: Professor Robert J. Denver, Chair Professor Daniel Goldman Professor Diane Robins Professor Audrey Seasholtz Associate Professor Bing Ye ©Joseph R. Knoedler All Rights Reserved 2016 To my parents, who never once questioned my decision to become the other kind of doctor, And to Lucy, who has pushed me to be a better person from day one. ii Acknowledgements I have a huge number of people to thank for having made it to this point, so in no particular order: -I would like to thank my adviser, Dr. Robert J. Denver, for his guidance, encouragement, and patience over the last seven years; his mentorship has been indispensable for my growth as a scientist -I would also like to thank my committee members, Drs. Audrey Seasholtz, Dan Goldman, Diane Robins and Bing Ye, for their constructive feedback and their willingness to meet in a frequently cold, windowless room across campus from where they work -I am hugely indebted to Pia Bagamasbad and Yasuhiro Kyono for teaching me almost everything I know about molecular biology and bioinformatics, and to Arasakumar Subramani for his tireless work during the home stretch to my dissertation -I am grateful for the Neuroscience Program leadership and staff, in particular
    [Show full text]
  • Ctbp1/2 Differentially Regulate Genomic Stability and DNA Repair
    Oncogenesis www.nature.com/oncsis ARTICLE OPEN CtBP1/2 differentially regulate genomic stability and DNA repair pathway in high-grade serous ovarian cancer cell ✉ YingYing He 1, Zhicheng He 2,3, Jian Lin 2,3, Cheng Chen2,3, Yuanzhi Chen 2,3 and Shubai Liu 2,3 © The Author(s) 2021 The C-terminal binding proteins (CtBPs), CtBP1 and CtBP2, are transcriptional co-repressor that interacts with multiple transcriptional factors to modulate the stability of chromatin. CtBP proteins were identified with overexpression in the high-grade serous ovarian carcinoma (HGSOC). However, little is known about CtBP proteins’ regulatory roles in genomic stability and DNA repair in HGSOC. In this study, we combined whole-transcriptome analysis with multiple research methods to investigate the role of CtBP1/2 in genomic stability. Several key functional pathways were significantly enriched through whole transcription profile analysis of CtBP1/2 knockdown SKOV3 cells, including DNA damage repair, apoptosis, and cell cycle. CtBP1/2 knockdown induced cancer cell apoptosis, increased genetic instability, and enhanced the sensitivity to DNA damage agents, such as γ-irradiation and chemotherapy drug (Carboplatin and etoposide). The results of DNA fiber assay revealed that CtBP1/2 contribute differentially to the integrity of DNA replication track and stability of DNA replication recovery. CtBP1 protects the integrity of stalled forks under metabolic stress condition during prolonged periods of replication, whereas CtBP2 acts a dominant role in stability of DNA replication recovery. Furthermore, CtBP1/2 knockdown shifted the DSBs repair pathway from homologous recombination (HR) to non-homologous end joining (NHEJ) and activated DNA-PK in SKOV3 cells.
    [Show full text]
  • A Role for Mediator Complex Subunit MED13L in Rb&Sol;E2F-Induced
    Oncogene (2012) 31, 4709 --4717 & 2012 Macmillan Publishers Limited All rights reserved 0950-9232/12 www.nature.com/onc ORIGINAL ARTICLE A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest SP Angus and JR Nevins The Rb/E2F pathway is deregulated in virtually all human tumors. It is clear that, in addition to Rb itself, essential cofactors required for transcriptional repression and silencing of E2F target genes are mutated or lost in cancer. To identify novel cofactors required for Rb/E2F-mediated inhibition of cell proliferation, we performed a genome-wide short hairpin RNA screen. In addition to several known Rb cofactors, the screen identified components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription. We show that the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition. Oncogene (2012) 31, 4709--4717; doi:10.1038/onc.2011.622; published online 16 January 2012 Keywords: tumor suppressor; cell cycle; senescence INTRODUCTION Typically, the levels of CDKN2A are greatly increased, leading to The retinoblastoma tumor suppressor (Rb) is a critical negative the accumulation of active, hypophosphorylated Rb. Senescent regulator of cellular proliferation that is frequently inactivated in cells characteristically exhibit flat-cell morphology and are positive 20 human cancer.1,2 In its active form, Rb binds to the members of for senescence-associated beta-galactosidase (SA-b-gal) activity. 21 the E2F family of transcription factors and either suppresses their Additionally, Narita et al. described the formation of senescence- transactivation function or assembles an active repressor com- associated heterochromatic foci at E2F promoters during V12 plex.3 E2F family members are essential regulators of genes Ras -induced senescence.
    [Show full text]
  • Defining the Role of Ctbp2 in P53-Independent Umort Suppressor Function of ARF: a Dissertation
    University of Massachusetts Medical School eScholarship@UMMS GSBS Dissertations and Theses Graduate School of Biomedical Sciences 2009-06-11 Defining the Role of CtBP2 in p53-Independent umorT Suppressor Function of ARF: A Dissertation Ramesh C. Kovi University of Massachusetts Medical School Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss Part of the Amino Acids, Peptides, and Proteins Commons, Cells Commons, Genetic Phenomena Commons, and the Neoplasms Commons Repository Citation Kovi RC. (2009). Defining the Role of CtBP2 in p53-Independent umorT Suppressor Function of ARF: A Dissertation. GSBS Dissertations and Theses. https://doi.org/10.13028/86d1-1y04. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/433 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Defining the Role of CtBP2 in p53-independent Tumor Suppressor Function of ARF A Dissertation Presented By Ramesh C. Kovi Submitted to the Faculty of the University of Massachusetts Graduate School of Biomedical Sciences, Worcester in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY CANCER BIOLOGY June 11, 2009 TO THE CHERISHED MEMORY OF MY MOTHER Mrs. CHOWDAMMA iv Copyright Notice Parts of this dissertation have appeared in separate publications: Kovi RC, Paliwal S, Pande S and Grossman SR. 2009. An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis. Cell Death and Differentiation (in press).
    [Show full text]